Department of Genetics, Aravind Medical Research Foundation, Dr G. Venkataswamy Eye Research Institute, Madurai, India.
Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Rockville, Maryland.
JAMA Ophthalmol. 2014 Aug;132(8):949-55. doi: 10.1001/jamaophthalmol.2014.845.
This study was necessary to establish the association between common genetic variants in the lysyl oxidase-like 1 (LOXL1) gene with pseudoexfoliation (PEX) syndrome and emphasize the reversal of promoter risk allele in a South Indian population.
To investigate the potential association of genetic variants across the LOXL1 gene in South Indian patients with PEX syndrome and glaucoma.
DESIGN, SETTING, AND PARTICIPANTS: A case-control study of individuals from Madurai, India, with PEX syndrome and glaucoma as well as healthy people serving as controls. Three hundred unrelated people with PEX syndrome and 225 age- and ethnically matched controls were recruited for genetic analysis.
Four single-nucleotide polymorphisms in LOXL1 (rs16958477, rs1048661, rs3825942, and rs2165241) were genotyped by direct sequencing in all participants. Regulatory regions and 7 coding exons of LOXL1 were directly sequenced in 50 patients and 50 controls. A case-control association analysis was performed using the Golden Helix SVS suite.
An association between 4 LOXL1 single-nucleotide polymorphisms with PEX syndrome and glaucoma was observed (rs16958477, P = 4.77 × 10-6 [odds ratio, 0.50]; rs1048661, P = 4.28 × 10-5 [1.79]; rs3825942, P = 4.68 × 10-30 [9.19]; and rs2165241, P = 1.98 × 10-15 [2.88]). Sequencing of 7 exons and regulatory regions of LOXL1 identified 11 additional sequence variants; only rs41435250 showed an association (P = 3.80 × 10-5 [0.49]) with PEX syndrome and glaucoma.
Genetic variants in LOXL1 are associated with PEX syndrome and glaucoma in the South Indian population. To our knowledge, this is the first study to demonstrate the association of rs41435250 with PEX as well as reversal of the promoter risk allele. Understanding the role of the LOXL1 gene in PEX pathogenesis will facilitate early detection in individuals at risk for this condition.
本研究旨在确定赖氨酸氧化酶样 1(LOXL1)基因中的常见遗传变异与假性剥脱(PEX)综合征之间的关联,并强调在印度南部人群中逆转启动子风险等位基因。
调查 LOXL1 基因中遗传变异与印度南部 PEX 综合征和青光眼患者的潜在关联。
设计、地点和参与者:这项病例对照研究纳入了来自印度马杜赖的 PEX 综合征和青光眼患者以及健康对照者。共招募了 300 名无血缘关系的 PEX 综合征患者和 225 名年龄和种族匹配的对照者进行基因分析。
对所有参与者进行直接测序,检测 LOXL1 中的 4 个单核苷酸多态性(rs16958477、rs1048661、rs3825942 和 rs2165241)。对 50 例患者和 50 例对照者的 LOXL1 调控区和 7 个编码外显子进行直接测序。采用 Golden Helix SVS 套件进行病例对照关联分析。
观察到 4 个 LOXL1 单核苷酸多态性与 PEX 综合征和青光眼相关(rs16958477,P=4.77×10-6[比值比,0.50];rs1048661,P=4.28×10-5[1.79];rs3825942,P=4.68×10-30[9.19];rs2165241,P=1.98×10-15[2.88])。对 LOXL1 的 7 个外显子和调控区进行测序,发现了 11 个额外的序列变异;只有 rs41435250 与 PEX 综合征和青光眼相关(P=3.80×10-5[0.49])。
LOXL1 中的遗传变异与印度南部人群的 PEX 综合征和青光眼相关。据我们所知,这是第一项证明 rs41435250 与 PEX 以及启动子风险等位基因逆转相关的研究。了解 LOXL1 基因在 PEX 发病机制中的作用将有助于对该疾病高危个体进行早期检测。